Currentblue cross blue shield - louisianaPolicy AHS - G2061 - Fecal Calprotectin Testing in Adults

G2061: Fecal Calprotectin Testing in Adults

Defines coverage criteria for fecal calprotectin testing for individuals aged 18 years and older, including when testing to differentiate IBD from IBS and for monitoring response/relapse in IBD; excludes other uses. Provides background, guideline alignment, FDA device summaries, and one CPT code reference.

Policy Summary

Payerblue cross blue shield - louisiana

PolicyG2061: Fecal Calprotectin Testing in Adults

Policy CodePolicy AHS - G2061 - Fecal Calprotectin Testing in Adults

Change TypeProposed for archival (content moved to G2121); prior clarifying revisions

Effective DateMay 15, 2022

Next Review Date

Key ActionConfirm and document that the individual is 18 years of age or older as the policy is specific to adults

SourceLink

POLICY UPDATE CHANGES

01/01/2025: Updated background, guidelines, and references; clarified that policy applies to adults (18+) and simplified Section III wording without changing coverage criteria.

02/01/2026: Proposed for archival; clinical information and coverage criteria moved to G2121.

02/01/2026: Proposed for Archival; clinical information and coverage criteria moved to G2121.

01/01/2025: Reviewed and Updated; clarified that policy is specific to adults (18+) and simplified coverage criteria wording; updated description for CPT 83993.

05/01/2024: Reviewed and Updated; background, guidelines and references updated without changes to coverage criteria.

03/10/2023: Updated background, guidelines and references; clarified coverage criteria language.

05/15/2022: Initial Policy Implementation

2Covered Indications (differential diagnosis; monitoring/response/relapse)